A3 adenosine receptor agonists for the reduction of...

Details A3 adenosine receptor agonists for the reduction of... A3 adenosine receptor agonists for the reduction of...

A - Human Necessities

61

K

A61K 31/7076 (2006.01) A61P 27/06 (2006.01)

Patent

CA 2761499

The present disclosure provides the use of an A3R agonist, such as IB-MECA, for reducing in a subject, preferably, human subject, intra ocular pressure (IOP). Similarly, the invention provides a pharmaceutical composition and a method for reducing IOP in a subject making use of the A3R agonist.

La présente invention porte sur l'utilisation d'un agoniste A3R, tel que IB-MECA, pour réduire chez un sujet, de préférence un sujet humain, la pression intraoculaire (IOP). De façon similaire, l'invention porte sur une composition pharmaceutique et sur un procédé pour réduire l'IOP chez un sujet à l'aide de l'agoniste A3R.

Affiliated with

Also associated with

Rating

A3 adenosine receptor agonists for the reduction of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with A3 adenosine receptor agonists for the reduction of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A3 adenosine receptor agonists for the reduction of... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1696236